Publications by authors named "Peter Dreger"

99Publications

Assessment of CAR T Cell Frequencies in Axicabtagene Ciloleucel and Tisagenlecleucel Patients Using Duplex Quantitative PCR.

Cancers (Basel) 2020 Sep 30;12(10). Epub 2020 Sep 30.

Department of Internal Medicine V (Hematology/Oncology/Rheumatology), University Hospital Heidelberg, 69120 Heidelberg, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3390/cancers12102820DOI Listing
September 2020

Interleukin-18 and Hematopoietic Recovery after Allogeneic Stem Cell Transplantation.

Cancers (Basel) 2020 Sep 28;12(10). Epub 2020 Sep 28.

Department of Internal Medicine V, University Hospital Heidelberg, 69120 Heidelberg, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3390/cancers12102789DOI Listing
September 2020

Comments on "Cost of decentralized CAR T cell production in an academic non-profit setting".

Int J Cancer 2020 Aug 15. Epub 2020 Aug 15.

Department of Internal Medicine V, Hematology, Oncology, Rheumatology, University Hospital Heidelberg, Heidelberg, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ijc.33254DOI Listing
August 2020

Feasibility and Safety of CD19 Chimeric Antigen Receptor T Cell Treatment for B Cell Lymphoma Relapse after Allogeneic Hematopoietic Stem Cell Transplantation.

Biol Blood Marrow Transplant 2020 Sep 15;26(9):1575-1580. Epub 2020 May 15.

Department of Internal Medicine V, University of Heidelberg, Heidelberg, Germany; German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ)/National Centre for Tumor Diseases (NCT), Heidelberg, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2020.04.025DOI Listing
September 2020

Influencing factors of cardiorespiratory fitness in allogeneic stem cell transplant candidates prior to transplantation.

Support Care Cancer 2020 May 4. Epub 2020 May 4.

Department of Medical Oncology, National Center for Tumor Diseases (NCT), Heidelberg University Hospital, Im Neuenheimer Feld 460, 69120, Heidelberg, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00520-020-05485-yDOI Listing
May 2020

B-cell maturation antigen-specific chimeric antigen receptor T cells for multiple myeloma: Clinical experience and future perspectives.

Int J Cancer 2020 Oct 30;147(8):2029-2041. Epub 2020 Apr 30.

Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ijc.33002DOI Listing
October 2020

High leukemia-free survival after TBI-based conditioning and mycophenolate mofetil-containing immunosuppression in patients allografted for chronic myelomonocytic leukemia: a single-center experience.

Ann Hematol 2020 Apr 8;99(4):855-866. Epub 2020 Feb 8.

Department of Internal Medicine V, University Hospital Heidelberg, Im Neuenheimer Feld 410, 69120, Heidelberg, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00277-020-03952-4DOI Listing
April 2020

CXCL9 predicts Severity at Onset of Chronic Graft-Versus-Host Disease.

Transplantation 2020 Jan 2. Epub 2020 Jan 2.

Department of Hematology and Oncology, University of Heidelberg, Heidelberg, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/TP.0000000000003108DOI Listing
January 2020

EASIX for prediction of survival in lower-risk myelodysplastic syndromes.

Blood Cancer J 2019 11 11;9(11):85. Epub 2019 Nov 11.

Department of Internal Medicine V, University Hospital Heidelberg, Heidelberg, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41408-019-0247-zDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6848148PMC
November 2019

Interleukin-18 and outcome after allogeneic stem cell transplantation: A retrospective cohort study.

EBioMedicine 2019 Nov 1;49:202-212. Epub 2019 Nov 1.

Department of Internal Medicine V, University Hospital Heidelberg, Im Neuenheimer Feld 410, 69120 Heidelberg Germany. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ebiom.2019.10.024DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6945194PMC
November 2019

Treosulfan or busulfan plus fludarabine as conditioning treatment before allogeneic haemopoietic stem cell transplantation for older patients with acute myeloid leukaemia or myelodysplastic syndrome (MC-FludT.14/L): a randomised, non-inferiority, phase 3 trial.

Lancet Haematol 2020 Jan 9;7(1):e28-e39. Epub 2019 Oct 9.

Department of Haematology and Bone Marrow Transplantation, Medical University of Silesia, Katowice, Poland; Faculty of Medicine, University of Rzeszow, Rzeszow, Poland.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S23523026193015
Publisher Site
http://dx.doi.org/10.1016/S2352-3026(19)30157-7DOI Listing
January 2020

EASIX and mortality after allogeneic stem cell transplantation.

Bone Marrow Transplant 2020 Mar 26;55(3):553-561. Epub 2019 Sep 26.

Charité Universitätsmedizin Berlin, Hematology, Oncology and Tumorimmunology, Berlin, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41409-019-0703-1DOI Listing
March 2020

Comment to "The outcome of peripheral T-cell lymphoma patients failing first-line therapy".

Authors:
Peter Dreger

Haematologica 2019 04;104(4):e178

Department of Medicine V, University of Heidelberg, Germany

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3324/haematol.2018.206904DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6442951PMC
April 2019

Chimeric Antigen Receptor (CAR) T Cell Therapy in Acute Myeloid Leukemia (AML).

J Clin Med 2019 Feb 6;8(2). Epub 2019 Feb 6.

Department of Internal Medicine V (Hematology/Oncology/Rheumatology), University Hospital Heidelberg, 69120 Heidelberg, Germany.

View Article

Download full-text PDF

Source
http://www.mdpi.com/2077-0383/8/2/200
Publisher Site
http://dx.doi.org/10.3390/jcm8020200DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6406805PMC
February 2019

Cell-based immunotherapy approaches for multiple myeloma.

Br J Cancer 2019 01 6;120(1):38-44. Epub 2018 Dec 6.

Department of Hematology, Oncology and Rheumatology, Heidelberg University, Heidelberg, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41416-018-0346-9DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6325139PMC
January 2019

The role of stem cell transplantation in the management of relapsed follicular lymphoma in the era of targeted therapies.

Bone Marrow Transplant 2019 06 2;54(6):787-797. Epub 2018 Nov 2.

Department of Haematology, Bristol Oncology and Haematology Centre, Bristol, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41409-018-0372-5DOI Listing
June 2019

Influence of Retronectin-Mediated T-Cell Activation on Expansion and Phenotype of CD19-Specific Chimeric Antigen Receptor T Cells.

Hum Gene Ther 2018 10 5;29(10):1167-1182. Epub 2018 Sep 5.

1 Department of Medicine V, Heidelberg University Hospital , Heidelberg, Germany; and German Cancer Consortium, Heidelberg, Germany .

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1089/hum.2017.237DOI Listing
October 2018

A prospective study on serum Cytokeratin (CK)-18 and CK18 fragments as biomarkers of acute hepato-intestinal GVHD.

Leukemia 2018 12 27;32(12):2685-2692. Epub 2018 Jun 27.

Department of Hematology and Oncology, University of Heidelberg, Heidelberg, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41375-018-0183-0DOI Listing
December 2018

Antibodies conjugated with viral antigens elicit a cytotoxic T cell response against primary CLL ex vivo.

Leukemia 2019 01 20;33(1):88-98. Epub 2018 Jun 20.

German Cancer Research Center (DKFZ), Unit F100, 69120, Heidelberg, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41375-018-0160-7DOI Listing
January 2019

Reply to the persistent uncertainty of when to recommend allogeneic stem cell transplantation in follicular iymphoma.

Cancer 2018 08 7;124(16):3455-3456. Epub 2018 Jun 7.

Center for International Blood and Marrow Transplant Research, Department of Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.31564DOI Listing
August 2018

CD7 is expressed on a subset of normal CD34-positive myeloid precursors.

Eur J Haematol 2018 Sep 4;101(3):318-325. Epub 2018 Jul 4.

Department of Hematology, Oncology and Rheumatology, University of Heidelberg, Heidelberg, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/ejh.13100DOI Listing
September 2018

Prevention and treatment of relapse after stem cell transplantation in lymphoid malignancies.

Bone Marrow Transplant 2019 01 24;54(1):17-25. Epub 2018 May 24.

Division of Hematology Oncology, Blood and Marrow Transplant Program, University of Pennsylvania and Perelman School of Medicine, Philadelphia, PA, 19104, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41409-018-0214-5DOI Listing
January 2019

Autologous Stem Cell Transplantation for Patients with Early Progression of Follicular Lymphoma: A Follow-Up Study of 2 Randomized Trials from the German Low Grade Lymphoma Study Group.

Biol Blood Marrow Transplant 2018 06 29;24(6):1172-1179. Epub 2018 Mar 29.

Department of Internal Medicine III, University Hospital of the Ludwig-Maximilians-University, Munich, Germany; German Cancer Consortium (DKTK), Heidelberg, Germany; German Cancer Research Centre (DKFZ), Heidelberg, Germany. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2018.03.022DOI Listing
June 2018

The impact of stem cell transplantation on the natural course of peripheral T-cell lymphoma: a real-world experience.

Ann Hematol 2018 Jul 16;97(7):1241-1250. Epub 2018 Mar 16.

Department of Medicine V, University of Heidelberg, Im Neuenheimer Feld 410, 69120, Heidelberg, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00277-018-3288-7DOI Listing
July 2018

Single Nucleotide Polymorphisms in CD40L Predict Endothelial Complications and Mortality After Allogeneic Stem-Cell Transplantation.

J Clin Oncol 2018 03 25;36(8):789-800. Epub 2018 Jan 25.

Sivaramakrishna P. Rachakonda, Hao Dai, and Rajiv Kumar, German Cancer Research Centre; Sivaramakrishna P. Rachakonda, Aleksandar Radujkovic, Carsten Müller-Tidow, Peter Dreger, and Thomas Luft, University Hospital Heidelberg, Heidelberg; and Olaf Penack, Olga Blau, and Igor Wolfgang Blau, Charité University Medicine Berlin, Berlin, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2017.76.4662DOI Listing
March 2018

Chimeric antigen receptor transduced T cells: Tuning up for the next generation.

Int J Cancer 2018 05 27;142(9):1738-1747. Epub 2017 Nov 27.

Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ijc.31147DOI Listing
May 2018

Post-Transplantation Cyclophosphamide-Based Haploidentical Transplantation as Alternative to Matched Sibling or Unrelated Donor Transplantation for Hodgkin Lymphoma: A Registry Study of the Lymphoma Working Party of the European Society for Blood and Marrow Transplantation.

J Clin Oncol 2017 Oct 28;35(30):3425-3432. Epub 2017 Aug 28.

Carmen Martínez, Institute of Hematology and Oncology, Hospital Clínic; Carmen Canals, Banc de Sang i Teixits; Anna Sureda, Institut Català d'Oncologia, Hospital Duran i Reynals, Barcelona; Jorge Gayoso, Hospital General Universitario Gregorio Marañón, Madrid; Arancha Bermúdez, Hospital Universitario Marqués de Valdecilla, Cantabria, Spain; Carmen Martínez, Hervé Finel, Silvia Montoto, Peter Dreger, and Anna Sureda, European Society for Blood and Marrow Transplantation, Paris; Didier Blaise, Institut Paoli Calmettes, Marseille; Edouard Forcade, University Hospital of Bordeaux, Bordeaux; Ibrahim Yakoub-Agha, Centre Hospitalier Regional Universitaire de Lille, Lille Inflammation Research International Center, Institut National de la Santé et de la Recherche Médicale U995, Lille, France; Karl Peggs, University College London Cancer Institute; Michael Potter, The Royal Marsden Hospital; Silvia Montoto, St Bartholomew's Hospital, Barts Health National Health Service Trust, London; Stephen Robinson, Bristol Haematology and Oncology Centre, Bristol; Grant McQuaker, Gartnaval General Hospital, Glasgow; Adrian Bloor, Christie National Health Service Trust Hospital, Manchester, United Kingdom; Alida Dominietto, Istituto di Ricovero e Cura a Carattere Scientifico per l'Oncologia, Azienda Ospedaliera-Universitaria San Martino-IST, Genova; Luca Castagna, Istituto Clinico Humanitas; Paolo Corradini, Istituto Nazionale dei Tumori, Milan; Domenico Russo, University of Brescia, Brescia, Italy; Boris Afanasyev, First Pavlov State Medical University of St Petersburg, St Petersburg, Russia; Maija Itälä-Remes, Turku University Hospital, Turku, Finland; Christof Scheid, University of Cologne, Cologne; and Peter Dreger, University of Heidelberg, Heidelberg, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2017.72.6869DOI Listing
October 2017

Pretransplant Vitamin D Deficiency Is Associated With Higher Relapse Rates in Patients Allografted for Myeloid Malignancies.

J Clin Oncol 2017 Sep 3;35(27):3143-3152. Epub 2017 Aug 3.

Aleksandar Radujkovic, Nicola Lehners, Katharina Schmidt, Peter Dreger, and Thomas Luft, University Hospital Heidelberg; Julia Krzykalla and Axel Benner, German Cancer Research Center, Heidelberg; and Lambros Kordelas and Dietrich W. Beelen, University Hospital, Essen, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2017.73.0085DOI Listing
September 2017

EASIX in patients with acute graft-versus-host disease: a retrospective cohort analysis.

Lancet Haematol 2017 Sep 18;4(9):e414-e423. Epub 2017 Jul 18.

Charité University Medicine Berlin, Haematology, Oncology and Tumorimmunology, Berlin, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S2352-3026(17)30108-4DOI Listing
September 2017

Impact of HSCT Conditioning and Glucocorticoid Dose on Exercise Adherence and Response.

Med Sci Sports Exerc 2017 Nov;49(11):2143-2150

1Department of Medical Oncology, National Center for Tumor Diseases (NCT) and Heidelberg University Hospital, Heidelberg, GERMANY; 2Division of Physical Activity, Prevention and Cancer, National Center for Tumor Diseases (NCT) and German Cancer Research Center (DKFZ), Heidelberg, GERMANY; 3Bone Marrow Transplant Unit, German Clinic for Diagnostics, Wiesbaden, GERMANY; 4Department of Medicine V, Heidelberg University Hospital, Heidelberg, GERMANY; 5Central Institute of Mental Health, Mannheim, GERMANY; and 6Faculty of Health, University of Antwerp, BELGIUM.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1249/MSS.0000000000001357DOI Listing
November 2017

Dose-Reduced Versus Standard Conditioning Followed by Allogeneic Stem-Cell Transplantation for Patients With Myelodysplastic Syndrome: A Prospective Randomized Phase III Study of the EBMT (RICMAC Trial).

J Clin Oncol 2017 Jul 2;35(19):2157-2164. Epub 2017 May 2.

Nicolaus Kröger, University Medical Center Hamburg-Eppendorf, Hamburg; Georg-Nikolaus Franke, University Hospital Leipzig, Leipzig; Uwe Platzbecker, University Hospital Dresden, Dresden; Kai Hübel and Christof Scheid, University of Cologne, Cologne; Thomas Weber, University Hospital Halle (Saale), Martin-Luther-University Halle-Wittenberg, Halle; Matthias Stelljes, University of Münster, Münster; Peter Dreger, University of Heidelberg, Heidelberg; Andreas Günther, University Hospital Schleswig Holstein Campus Kiel, Kiel; Wolfgang Bethge, University Hospital Tübingen, Tübingen; Guido Kobbe, Heinrich Heine University, Düsseldorf, Germany; Simona Iacobelli, Università Tor Vergata, Rome; Giorgio Lambertenghi Deliliers and Francesco Onida, Fondazione IRCC Ca' Granda Ospedale Maggiore Policlinico, University of Milano, Milan; Massimo Pini, Azienda Ospedaliera SS. Antonio e Biagio e Cesare Arrigo, Alessandria; Stefano Guidi, Azienda Ospedaliera Universitaria Careggi, Florence, Italy; Ruzena Uddin, Guy's Hospital, London, United Kingdom; Marie Robin, Hôpital Saint Louis, Assistance Publique Hôpitaux Paris, France; Boris Afanasyev, SPB Pavlov Medical University, St Petersburg, Russia; Dominik Heim, University Hospital Basel, Basel Switzerland; Liisa Volin, Helsinki University Hospital, Helsiniki, Finland; Xavier Poiré, Cliniques Universitaires St-Luc, Brussels, Belgium; Marleen van Os, European Group of Blood and Marrow Transplantation Clinical Trials Office; Ronald Brand, Leiden University Medical Center, Leiden; and Theo de Witte, Radboud University Medical Center, Nijmegen, the Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.70.7349DOI Listing
July 2017

Prospective noninterventional study on peripheral blood stem cell mobilization in patients with relapsed lymphomas.

J Clin Apher 2017 Oct 10;32(5):295-301. Epub 2016 Sep 10.

Department of Hematology, Maastricht University Medical Center, Maastricht, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/jca.21506DOI Listing
October 2017